Literature DB >> 8567267

[Hair-like hyperkeratoses in patients with kidney transplants. A new cyclosporin side-effect].

J Izakovic1, S A Büchner, M Düggelin, R Guggenheim, P H Itin.   

Abstract

We report a 31-year-old renal transplant patient treated with cyclosporin A who developed an unusual sebaceous gland hyperplasia accompanied by a disseminated follicular spiny hyperkeratosis. Those alterations were most evident on his face and limbs. In some locations hairy hyperkeratosis with authentic hair neogenesis was found. The histology of these alterations showed a marked hyperkeratosis of the hair follicles with formation of hair-like spikes either alone or in connection with hairs. The presence of true hairs distinguishes our case from the morphologically similar disseminated spiked hyperkeratosis and other spiny keratinization disorders. Scanning electron microscopy helped to demonstrate the hair-like structure of these keratoses. Some of the sebaceous glands showed cystic widening of their lumina, which were filled with abundant amorphous eosinophilic material, a finding similar to earlier observations. Our case demonstrates that these skin alterations should be classified as side effects of cyclosporin A and that they are apparently dose-dependent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567267     DOI: 10.1007/s001050050350

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  13 in total

1.  ALTERNATIVE METHODS FOR SEQUENCING FULL TSPyV GENOMES USING SANGER OR NGS.

Authors:  Paulo Roberto Urbano; Ana Carolina Soares de Oliveira; Camila Malta Romano
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-12-08       Impact factor: 1.846

Review 2.  Viral-associated trichodysplasia spinulosa: a case with electron microscopic and molecular detection of the trichodysplasia spinulosa-associated human polyomavirus.

Authors:  Mark R Matthews; Richard C Wang; Robert L Reddick; Victor A Saldivar; John C Browning
Journal:  J Cutan Pathol       Date:  2011-01-19       Impact factor: 1.587

3.  Trichodysplasia Spinulosa in a 7-Year-Old Boy Managed Using Physical Extraction of Keratin Spicules.

Authors:  Michael Barton; Suing Lockhart; Robert Sidbury; Richard Wang; Heather Brandling-Bennett
Journal:  Pediatr Dermatol       Date:  2016-12-19       Impact factor: 1.588

4.  Viral-associated trichodysplasia: characterization of a novel polyomavirus infection with therapeutic insights.

Authors:  Karolyn A Wanat; Phillip D Holler; Tzvete Dentchev; Kenneth Simbiri; Erle Robertson; John T Seykora; Misha Rosenbach
Journal:  Arch Dermatol       Date:  2012-02

Review 5.  [Human polyomavirus-associated skin diseases].

Authors:  Steffi Silling; Alexander Kreuter; Ulrike Wieland
Journal:  Hautarzt       Date:  2022-04-28       Impact factor: 0.751

6.  Benign and malignant skin lesions in renal transplant recipients.

Authors:  H Ghaninejad; A H Ehsani; M Ghiasi; P Noormohammadpour; E Najafi; G Naderi; M Ganji; M Mirnezami; R Nezami; P Kiani
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

7.  Trichodysplasia of immunosuppression treated with oral valganciclovir.

Authors:  Aton M Holzer; Lauren C Hughey
Journal:  J Am Acad Dermatol       Date:  2009-01       Impact factor: 11.527

8.  Crystallographic and glycan microarray analysis of human polyomavirus 9 VP1 identifies N-glycolyl neuraminic acid as a receptor candidate.

Authors:  Zaigham Mahmood Khan; Yan Liu; Ursula Neu; Michel Gilbert; Bernhard Ehlers; Ten Feizi; Thilo Stehle
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

9.  Two cases of trichodysplasia spinulosa responsive to compounded topical cidofovir 3% cream.

Authors:  Justin J Leitenberger; Mark Abdelmalek; Richard C Wang; Lynne Strasfeld; R Sam Hopkins
Journal:  JAAD Case Rep       Date:  2015-11-24

10.  Adult onset atopic dermatitis with secondary follicular mucinosis with cyclosporine induced spiny follicular hyperkeratosis and hair casts.

Authors:  Rameshwar M Gutte
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.